San Diego cell therapy CDMO acquired by Great Point Partners 13-Jan-2022 By Rachel Arthur Performance Cell Manufacturing, a CDMO with a focus on manufacturing cell therapies, has been acquired by Great Point Partners and will now operate under the name Cellipont Bioservices.
AstraZeneca opens new advanced therapeutics R&D facility in Cambridge 23-Nov-2021 By Jane Byrne AstraZeneca has built a new R&D facility - The Discovery Centre (DISC) - in Cambridge in the UK.